TCTMD News http://www.tctmd.com/news/rss TCTMD News en STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis http://www.tctmd.com/news/stemi-patients-multivessel-disease-best-served-single-complete-procedure-meta-analysis <span class="field field--name-title field--type-string field--label-hidden">STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/stemi-patients-multivessel-disease-best-served-single-complete-procedure-meta-analysis"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.15.17%20STEMI%20Patients%20With%20Multivessel%20Disease%20Best%20Served%20by%20a%20Single%20Procedure%20Meta-analysis.jpg?itok=GIA6AQMZ" width="220" height="124" alt="STEMI Patients With Multivessel Disease Best Served by a Single Procedure: Meta-analysis" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 12/15/2017 - 15:11</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Multivessel PCI is linked to less death and MI when done all at once, but not when done in a staged fashion.</div> Fri, 15 Dec 2017 20:11:47 +0000 yplata 25696 at http://www.tctmd.com Myocardial Perfusion Imaging May Enhance CT-Based Evaluation of Stable Angina: CRESCENT II http://www.tctmd.com/news/myocardial-perfusion-imaging-may-enhance-ct-based-evaluation-stable-angina-crescent-ii <span class="field field--name-title field--type-string field--label-hidden">Myocardial Perfusion Imaging May Enhance CT-Based Evaluation of Stable Angina: CRESCENT II</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/myocardial-perfusion-imaging-may-enhance-ct-based-evaluation-stable-angina-crescent-ii"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/Tier-1-Image%20Todds%20CT%20story-Header.jpg?itok=QjwfcXZ0" width="220" height="112" alt="Myocardial Perfusion Imaging May Enhance CT-Based Evaluation of Stable Angina: CRESCENT II" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 12/15/2017 - 13:47</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">A tiered approach with calcium scans, CT angiography, and perfusion imaging performs favorably against functional testing.</div> Fri, 15 Dec 2017 18:47:40 +0000 yplata 25694 at http://www.tctmd.com PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis http://www.tctmd.com/news/pci-comparable-cabg-left-main-coronary-disease-meta-analysis <span class="field field--name-title field--type-string field--label-hidden">PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/pci-comparable-cabg-left-main-coronary-disease-meta-analysis"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/Left-Main%20Header%20Updated.jpg?itok=YKJfr6Lw" width="220" height="118" alt="PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 12/14/2017 - 16:05</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The study reaffirms what was observed in the large EXCEL trial, suggesting PCI is acceptable option in left main disease, say researchers. </div> Thu, 14 Dec 2017 21:05:29 +0000 yplata 25692 at http://www.tctmd.com High-Sensitivity Troponin T Assay Picks Out Low-Risk Patients in US Emergency Departments http://www.tctmd.com/news/high-sensitivity-troponin-t-assay-picks-out-low-risk-patients-us-emergency-departments <span class="field field--name-title field--type-string field--label-hidden">High-Sensitivity Troponin T Assay Picks Out Low-Risk Patients in US Emergency Departments</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/high-sensitivity-troponin-t-assay-picks-out-low-risk-patients-us-emergency-departments"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.14.17%20High-Sensitivity%20Troponin%20T%20Assay%20Picks%20Out%20Low-Risk%20Patients%20in%20US%20Emergency%20Departments.jpg?itok=5qzmmC-W" width="220" height="121" alt="High-Sensitivity Troponin T Assay Picks Out Low-Risk Patients in US Emergency Departments" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 12/14/2017 - 13:00</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Assays like this are potential game changers, but they should be implemented carefully in the United States, one expert says. </div> Thu, 14 Dec 2017 18:00:22 +0000 yplata 25689 at http://www.tctmd.com Isolated Tricuspid Valve Surgery Remains Rare and Risky http://www.tctmd.com/news/isolated-tricuspid-valve-surgery-remains-rare-and-risky <span class="field field--name-title field--type-string field--label-hidden">Isolated Tricuspid Valve Surgery Remains Rare and Risky</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/isolated-tricuspid-valve-surgery-remains-rare-and-risky"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.13.17%20Isolated%20Tricuspid%20Valve%20Surgery%20Remains%20Rare%20and%20Risky.jpg?itok=D6thT2cR" width="220" height="117" alt="Isolated Tricuspid Valve Surgery Remains Rare and Risky" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 12/13/2017 - 15:53</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Over a decade, only 5,005 such surgeries were performed in the US. In-hospital mortality held steady at 8.8% despite rising experience.</div> Wed, 13 Dec 2017 20:53:00 +0000 yplata 25671 at http://www.tctmd.com Proximity to Physical Activity Facilities May Play Role in Body Fat Levels http://www.tctmd.com/news/proximity-physical-activity-facilities-may-play-role-body-fat-levels <span class="field field--name-title field--type-string field--label-hidden">Proximity to Physical Activity Facilities May Play Role in Body Fat Levels </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/proximity-physical-activity-facilities-may-play-role-body-fat-levels"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/exercise%20image.jpg?itok=Uk7EUtQR" width="220" height="111" alt="Proximity to Physical Activity Facilities May Play Role in Body Fat Levels " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 12/13/2017 - 11:53</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Future community development should focus on increasing access to gyms, parks, and pools to combat rising obesity rates, researchers say. </div> Wed, 13 Dec 2017 16:53:29 +0000 yplata 25667 at http://www.tctmd.com Episode 19: CULPRIT-SHOCK, On-site Impressions of TCT 2017, and More http://www.tctmd.com/audio/episode-19-culprit-shock-site-impressions-tct-2017-and-more <span class="field field--name-title field--type-string field--label-hidden">Episode 19: CULPRIT-SHOCK, On-site Impressions of TCT 2017, and More</span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 12/13/2017 - 11:23</span> <div class="field field--name-field-date field--type-datetime field--label-above"> <!-- <div class="field__label">Publish Date</div> --> <div class="field__item">2 days ago</div> </div> <div class="field field--name-field-teaser field--type-string-long field--label-above"> <!-- <div class="field__label">Teaser</div> --> <div class="field__item">Today’s episode is hosted by Michael Jaff. It covers everything from the CULPRIT-SHOCK trial to what it was like to be on-site in Denver, Colorado.</div> </div> Wed, 13 Dec 2017 16:23:03 +0000 yplata 25665 at http://www.tctmd.com Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk http://www.tctmd.com/news/coronary-cta-ed-chest-pain-ups-statins-aspirin-discharge-those-highest-risk <span class="field field--name-title field--type-string field--label-hidden">Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/coronary-cta-ed-chest-pain-ups-statins-aspirin-discharge-those-highest-risk"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.12.17%20Coronary%20CTA%20in%20the%20ED%20for%20Chest%20Pain%20Ups%20Statins%2C%20Aspirin%20on%20Discharge%20in%20Those%20at%20Highest%20Risk.jpg?itok=dWkUItVu" width="220" height="146" alt="Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 12/12/2017 - 14:12</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">A new analysis supports the argument that coronary CTA in the emergency department may lead better medical management of coronary disease. </div> Tue, 12 Dec 2017 19:12:38 +0000 yplata 25659 at http://www.tctmd.com Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors http://www.tctmd.com/news/subclinical-atherosclerosis-evident-half-adults-without-cvd-risk-factors <span class="field field--name-title field--type-string field--label-hidden">Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/subclinical-atherosclerosis-evident-half-adults-without-cvd-risk-factors"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.12.17%20Subclinical%20Atherosclerosis%20Evident%20in%20Half%20of%20Adults%20Without%20CVD%20Risk%20Factors.jpg?itok=Weu0XLUb" width="220" height="127" alt="Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 12/12/2017 - 12:07</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The results also highlight the critical role LDL plays in the early development of atherosclerosis, even when risk factor control is “optimal.”</div> Tue, 12 Dec 2017 17:07:22 +0000 yplata 25658 at http://www.tctmd.com USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women http://www.tctmd.com/news/uspstf-upholds-stance-against-hormone-therapy-prevent-chronic-diseases-menopausal-women <span class="field field--name-title field--type-string field--label-hidden">USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/uspstf-upholds-stance-against-hormone-therapy-prevent-chronic-diseases-menopausal-women"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.12.17%20USPSTF%20Upholds%20Stance%20Against%20Hormone%20Therapy%20to%20Prevent%20Chronic%20Diseases%20in%20Menopausal%20Women%20-%20Header.jpg?itok=GY1w11NB" width="220" height="120" alt="USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 12/12/2017 - 11:15</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">But the advice only applies to primary prevention, not symptom relief, experts caution.</div> Tue, 12 Dec 2017 16:15:07 +0000 yplata 25657 at http://www.tctmd.com Even After Recent ACS, Diabetic Patients With Multivessel Disease Fare Better With CABG http://www.tctmd.com/news/even-after-recent-acs-diabetic-patients-multivessel-disease-fare-better-cabg <span class="field field--name-title field--type-string field--label-hidden">Even After Recent ACS, Diabetic Patients With Multivessel Disease Fare Better With CABG</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/even-after-recent-acs-diabetic-patients-multivessel-disease-fare-better-cabg"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.11.17%20Even%20After%20Recent%20ACS%2C%20Diabetic%20Patients%20With%20Multivessel%20Disease%20Fare%20Better%20With%20CABG.jpg?itok=OADCwSKk" width="220" height="119" alt="Even After Recent ACS, Diabetic Patients With Multivessel Disease Fare Better With CABG" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 12/11/2017 - 14:17</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Five years after FREEDOM, the debate continues: new data are further validating the long-term cardiovascular benefits of surgery.</div> Mon, 11 Dec 2017 19:17:51 +0000 yplata 25656 at http://www.tctmd.com Hospital Mortality for Patients With A-fib Higher in Rural Areas http://www.tctmd.com/news/hospital-mortality-patients-fib-higher-rural-areas <span class="field field--name-title field--type-string field--label-hidden">Hospital Mortality for Patients With A-fib Higher in Rural Areas</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/hospital-mortality-patients-fib-higher-rural-areas"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.8.17%20Hospital%20Mortality%20for%20Patients%20With%20A-fib%20Higher%20in%20Rural%20Areas.jpg?itok=u2UxkIRx" width="220" height="110" alt="Hospital Mortality for Patients With A-fib Higher in Rural Areas" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 12/08/2017 - 17:08</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The findings should be “a motivational call to initiate prospective studies with the goal of identifying gaps in AF care,” editorialists say.</div> Fri, 08 Dec 2017 22:08:28 +0000 yplata 25655 at http://www.tctmd.com Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome http://www.tctmd.com/news/attacking-dvt-drug-device-combo-does-not-reduce-postthrombotic-syndrome <span class="field field--name-title field--type-string field--label-hidden">Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/attacking-dvt-drug-device-combo-does-not-reduce-postthrombotic-syndrome"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.8.17%20Attacking%20DVT.jpg?itok=GT9ADfVN" width="220" height="123" alt="Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 12/08/2017 - 10:42</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The ATTRACT trial failed to meet its primary endpoint, but there may remain a role for the approach in some patients.</div> Fri, 08 Dec 2017 15:42:55 +0000 yplata 25653 at http://www.tctmd.com Ditching Desflurane Could Help Reduce Carbon Footprint of Surgical Procedures http://www.tctmd.com/news/ditching-desflurane-could-help-reduce-carbon-footprint-surgical-procedures <span class="field field--name-title field--type-string field--label-hidden">Ditching Desflurane Could Help Reduce Carbon Footprint of Surgical Procedures</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/ditching-desflurane-could-help-reduce-carbon-footprint-surgical-procedures"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.8.17%20Ditching%20Desflurane%20Could%20Help%20Reduce%20Carbon%20Footprint%20of%20Surgical%20Procedures.jpg?itok=9vELL1TI" width="220" height="131" alt="Ditching Desflurane Could Help Reduce Carbon Footprint of Surgical Procedures" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 12/08/2017 - 15:55</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">A study performed in three countries hints that switching anesthetic agents may help cut down on significant greenhouse gas emissions.</div> Fri, 08 Dec 2017 20:55:44 +0000 yplata 25654 at http://www.tctmd.com Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US http://www.tctmd.com/news/hospital-readmission-patterns-post-mi-china-differ-markedly-us <span class="field field--name-title field--type-string field--label-hidden">Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/hospital-readmission-patterns-post-mi-china-differ-markedly-us"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.7.17%20Hospital%20Readmission%20Patterns%20Post-MI%20in%20China%20Differ%20Markedly%20From%20in%20the%20US%20Header.jpg?itok=Ac0no2th" width="220" height="115" alt="Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 12/07/2017 - 15:50</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The study highlights the “global burden” of readmissions following acute MI, one expert says.</div> Thu, 07 Dec 2017 20:50:30 +0000 yplata 25652 at http://www.tctmd.com Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events http://www.tctmd.com/news/surviving-cvd-obesity-offers-no-protection-those-new-onset-cardiac-events <span class="field field--name-title field--type-string field--label-hidden">Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/surviving-cvd-obesity-offers-no-protection-those-new-onset-cardiac-events"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.7.17%20Surviving%20CVD%20Obesity%20Offers%20No%20Protection%20for%20Those%20With%20New%20Onset%20Cardiac%20Events_1.jpg?itok=RxTfxVRg" width="220" height="131" alt="Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 12/07/2017 - 13:56</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The study challenges the paradoxical notion that overweight patients with CVD are at lower risk of death compared with normal-weight patients. </div> Thu, 07 Dec 2017 18:56:21 +0000 yplata 25650 at http://www.tctmd.com DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions http://www.tctmd.com/audio/dkcrush-v-randomized-trial-double-kissing-crush-vs-provisional-stenting-treatment-distal-left <span class="field field--name-title field--type-string field--label-hidden">DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions</span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 12/06/2017 - 17:23</span> <div class="field field--name-field-date field--type-datetime field--label-above"> <!-- <div class="field__label">Publish Date</div> --> <div class="field__item">1 week ago</div> </div> <div class="field field--name-field-teaser field--type-string-long field--label-above"> <!-- <div class="field__label">Teaser</div> --> <div class="field__item">C. Michael Gibson gets the details on this randomized trial of bifurcation stenting from Shao-Liang Chen. </div> </div> Wed, 06 Dec 2017 22:23:55 +0000 yplata 25649 at http://www.tctmd.com Better ECG Interpretation Criteria Needed for Professional Basketball Players, Study Suggests http://www.tctmd.com/news/better-ecg-interpretation-criteria-needed-professional-basketball-players-study-suggests <span class="field field--name-title field--type-string field--label-hidden">Better ECG Interpretation Criteria Needed for Professional Basketball Players, Study Suggests</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/better-ecg-interpretation-criteria-needed-professional-basketball-players-study-suggests"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.6.17%20Better%20ECG%20Interpretation%20Criteria%20Needed%20for%20Professional%20Basketball%20Players%2C%20Study%20Suggests.jpg?itok=XZrJdZLR" width="220" height="116" alt="Better ECG Interpretation Criteria Needed for Professional Basketball Players, Study Suggests" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 12/06/2017 - 10:51</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The high rate of ECG abnormalities in NBA players likely reflects false-positive findings, underscoring the need for better screening tests.</div> Wed, 06 Dec 2017 15:51:18 +0000 yplata 25646 at http://www.tctmd.com FDA Takes on 3-D Printing in Healthcare With Initial Guidance Document http://www.tctmd.com/news/fda-takes-3-d-printing-healthcare-initial-guidance-document <span class="field field--name-title field--type-string field--label-hidden">FDA Takes on 3-D Printing in Healthcare With Initial Guidance Document</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/fda-takes-3-d-printing-healthcare-initial-guidance-document"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.6.17%20FDA%20Takes%20on%203-D%20Printing%20in%20Healthcare%20With%20Initial%20Guidance%20Document.jpg?itok=GJtFwxz7" width="220" height="118" alt="FDA Takes on 3-D Printing in Healthcare With Initial Guidance Document" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 12/06/2017 - 13:08</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Amid growing interest in 3-D printing in medicine, the FDA is weighing in on device design, product testing, and quality system requirements.</div> Wed, 06 Dec 2017 18:08:04 +0000 yplata 25647 at http://www.tctmd.com Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality http://www.tctmd.com/news/myocardial-injury-after-noncardiac-surgery-linked-higher-1-year-mortality <span class="field field--name-title field--type-string field--label-hidden">Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/myocardial-injury-after-noncardiac-surgery-linked-higher-1-year-mortality"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.5.17%20Myocardial%20Injury%20After%20Noncardiac%20Surgery%20Linked%20With%20Higher%201-Year%20Mortality.jpg?itok=Z5b-rKLG" width="220" height="125" alt="Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 12/05/2017 - 17:35</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Even at a center where patients with high CV risk were routinely screened, perioperative damage had lasting consequences.</div> Tue, 05 Dec 2017 22:35:42 +0000 yplata 25645 at http://www.tctmd.com Diabetes Remission Possible With Significant Weight Loss: DiRECT http://www.tctmd.com/news/diabetes-remission-possible-significant-weight-loss-direct <span class="field field--name-title field--type-string field--label-hidden">Diabetes Remission Possible With Significant Weight Loss: DiRECT</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/diabetes-remission-possible-significant-weight-loss-direct"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.5.17%20Diabetes%20Remission%20Possible%20With%20Significant%20Weight%20Loss%20DiRECT%20header.jpg?itok=KiFFXUbN" width="220" height="123" alt="Diabetes Remission Possible With Significant Weight Loss: DiRECT" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 12/05/2017 - 17:01</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The dose-response effect seen with strict dietary intervention—allowing just 850 kcal/day—supports the link between diabetes and body fat.</div> Tue, 05 Dec 2017 22:01:50 +0000 yplata 25644 at http://www.tctmd.com Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial http://www.tctmd.com/news/dreams-dashed-intravascular-therapy-ms-flops-sham-controlled-trial <span class="field field--name-title field--type-string field--label-hidden">Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/dreams-dashed-intravascular-therapy-ms-flops-sham-controlled-trial"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.5.17%20Dreams%20Dashed%20Intravascular%20Therapy%20for%20MS%20Flops%20in%20Sham-Controlled%20Trial%20HEADER.jpg?itok=YjXF1kVj" width="220" height="125" alt="Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 12/05/2017 - 13:33</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The pioneer for the controversial technique who led the Brave Dreams trial now says “liberation therapy” is ineffective and warrants no further study.</div> Tue, 05 Dec 2017 18:33:21 +0000 yplata 25642 at http://www.tctmd.com Some Concerns About New ‘Tour de Force’ Hypertension Guidelines http://www.tctmd.com/news/some-concerns-about-new-tour-de-force-hypertension-guidelines <span class="field field--name-title field--type-string field--label-hidden">Some Concerns About New ‘Tour de Force’ Hypertension Guidelines</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/some-concerns-about-new-tour-de-force-hypertension-guidelines"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.4.17%20Some%20Concerns%20About%20New%20%E2%80%98Tour%20de%20Force%E2%80%99%20Hypertension%20Guidelines%20HEADER.jpg?itok=S2oUypCr" width="220" height="124" alt="Some Concerns About New ‘Tour de Force’ Hypertension Guidelines" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 12/04/2017 - 16:42</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Editorialists worry about the impact on policy and reimbursement, plus how widely the guidance will apply in primary care.</div> Mon, 04 Dec 2017 21:42:18 +0000 yplata 25639 at http://www.tctmd.com Burden of Readmission High in PAD Patients Following Revascularization http://www.tctmd.com/news/burden-readmission-high-pad-patients-following-revascularization <span class="field field--name-title field--type-string field--label-hidden">Burden of Readmission High in PAD Patients Following Revascularization</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/burden-readmission-high-pad-patients-following-revascularization"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.4.17%20Burden%20of%20Readmission%20High%20in%20PAD%20Patients%20Following%20Revascularization.jpg?itok=hCckV2yR" width="220" height="135" alt="Burden of Readmission High in PAD Patients Following Revascularization" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 12/04/2017 - 16:49</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Approximately one in six patients are readmitted within 30 days, most for procedure-related complications.</div> Mon, 04 Dec 2017 21:49:24 +0000 yplata 25640 at http://www.tctmd.com It’s Official: Evolocumab Gains Claim for CVD Event Reduction http://www.tctmd.com/news/its-official-evolocumab-gains-claim-cvd-event-reduction <span class="field field--name-title field--type-string field--label-hidden">It’s Official: Evolocumab Gains Claim for CVD Event Reduction</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/its-official-evolocumab-gains-claim-cvd-event-reduction"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.4.17%20It%E2%80%99s%20Official%20Evolocumab%20Gains%20Claim%20for%20CVD%20Event%20Reduction.jpg?itok=nlzkHFno" width="220" height="126" alt="It’s Official: Evolocumab Gains Claim for CVD Event Reduction" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 12/04/2017 - 15:02</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">(UPDATED) On the basis of the FOURIER trial, the FDA says evolocumab is now indicated for reducing the risk of MI, stroke, and revascularization. </div> Mon, 04 Dec 2017 20:02:10 +0000 yplata 25637 at http://www.tctmd.com ACC Provides Guidance on How to Manage Bleeding in Patients Taking Oral Anticoagulants http://www.tctmd.com/news/acc-provides-guidance-how-manage-bleeding-patients-taking-oral-anticoagulants <span class="field field--name-title field--type-string field--label-hidden">ACC Provides Guidance on How to Manage Bleeding in Patients Taking Oral Anticoagulants</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/acc-provides-guidance-how-manage-bleeding-patients-taking-oral-anticoagulants"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.4.17%20ACC%20Provides%20Guidance%20on%20How%20to%20Manage%20Bleeding%20in%20Patients%20Taking%20Oral%20Anticoagulants.jpg?itok=EUzfrb_R" width="220" height="124" alt="ACC Provides Guidance on How to Manage Bleeding in Patients Taking Oral Anticoagulants" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 12/04/2017 - 10:22</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The guidance, covering all drug indications, complements a prior document on periprocedural management of anticoagulation.</div> Mon, 04 Dec 2017 15:22:48 +0000 yplata 25634 at http://www.tctmd.com Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions http://www.tctmd.com/news/discrepant-ffr-and-ifr-results-may-signal-low-mace-risk-deferred-lesions <span class="field field--name-title field--type-string field--label-hidden">Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/discrepant-ffr-and-ifr-results-may-signal-low-mace-risk-deferred-lesions"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.1.17.%20Discrepant%20FFR%20and%20iFR%20Results%20May%20Signal%20Low%20MACE%20Risk%20in%20Deferred%20Lesions.jpg?itok=jHUUlQk1" width="220" height="146" alt="Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 12/01/2017 - 10:44</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Performing one physiologic assessment or the other seems to be more important than whether FFR or iFR is chosen, Allen Jeremias says.</div> Fri, 01 Dec 2017 15:44:11 +0000 yplata 25628 at http://www.tctmd.com More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine http://www.tctmd.com/news/more-headaches-premiums-publication-renews-debate-over-pfo-closure-migraine <span class="field field--name-title field--type-string field--label-hidden">More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/more-headaches-premiums-publication-renews-debate-over-pfo-closure-migraine"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/vector_image_updated_0.jpg?itok=dTGdU8TW" width="220" height="110" alt="More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 12/01/2017 - 14:35</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Some say honing patient selection will one day yield the answers; others insist migraine is far too complex for this intervention to work for many. </div> Fri, 01 Dec 2017 19:35:47 +0000 yplata 25631 at http://www.tctmd.com Secondary Prevention Improves Survival After STEMI Discharge but Is Widely Underprescribed http://www.tctmd.com/news/secondary-prevention-improves-survival-after-stemi-discharge-widely-underprescribed <span class="field field--name-title field--type-string field--label-hidden">Secondary Prevention Improves Survival After STEMI Discharge but Is Widely Underprescribed</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/secondary-prevention-improves-survival-after-stemi-discharge-widely-underprescribed"><img src="/sites/default/files/efs/public/styles/medium/public/2017-12/12.1.17%20Secondary%20Prevention%20Improves%20Survival%20After%20STEMI%20Discharge%20but%20Is%20Widely%20Underprescribed.jpg?itok=43Kbbk1-" width="220" height="130" alt="Secondary Prevention Improves Survival After STEMI Discharge but Is Widely Underprescribed" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 12/01/2017 - 12:14</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Patients who did not receive all recommended OMT were much more likely to die within a year than those getting prescriptions optimized at discharge.</div> Fri, 01 Dec 2017 17:14:41 +0000 yplata 25630 at http://www.tctmd.com New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry http://www.tctmd.com/news/new-generation-tavr-devices-outperform-predecessors-treating-pure-native-ar-registry <span class="field field--name-title field--type-string field--label-hidden">New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/new-generation-tavr-devices-outperform-predecessors-treating-pure-native-ar-registry"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/11.30.17.New%20Generation%20TAVR%20Devices%20Outperform%20Predecessors%20in%20Treating%20Pure%20Native%20AR%20Registry%20HEADER.jpg?itok=Bw33vxVS" width="220" height="115" alt="New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 11/30/2017 - 16:01</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Procedural outcomes are better with more recent valve models, with moderate or worse postprocedural AR linked to higher mortality.</div> Thu, 30 Nov 2017 21:01:57 +0000 yplata 25626 at http://www.tctmd.com FDA Approves EluNIR Drug-Eluting Stent http://www.tctmd.com/news/fda-approves-elunir-drug-eluting-stent <span class="field field--name-title field--type-string field--label-hidden">FDA Approves EluNIR Drug-Eluting Stent </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 11/30/2017 - 15:32</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The device, which has the narrowest strut width of any stent on the market, was approved on the basis of the nearly 2,000-patient BIONICS study. </div> Thu, 30 Nov 2017 20:32:02 +0000 yplata 25623 at http://www.tctmd.com Genetic Study Hints at Role of Lipids in AAA Risk http://www.tctmd.com/news/genetic-study-hints-role-lipids-aaa-risk <span class="field field--name-title field--type-string field--label-hidden">Genetic Study Hints at Role of Lipids in AAA Risk</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/genetic-study-hints-role-lipids-aaa-risk"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/11.30.17%20Genetic%20Study%20Hints%20at%20Role%20of%20Lipids%20in%20AAA%20Risk.jpg?itok=jEMAdKrP" width="220" height="123" alt="Genetic Study Hints at Role of Lipids in AAA Risk" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 11/30/2017 - 12:53</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Lipid-modifying drugs, like statins, PCSK9 inhibitors, and CETP inhibitors, could be repurposed for testing in AAA, say researchers. </div> Thu, 30 Nov 2017 17:53:48 +0000 yplata 25621 at http://www.tctmd.com iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI http://www.tctmd.com/news/ifr-may-help-rule-out-significant-nonculprit-lesions-after-primary-pci <span class="field field--name-title field--type-string field--label-hidden">iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/ifr-may-help-rule-out-significant-nonculprit-lesions-after-primary-pci"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/11.30.17%20iFR%20May%20Help%20Rule%20Out%20Significant%20Nonculprit%20Lesions%20After%20Primary%20PCI.jpg?itok=NQ93UlKF" width="220" height="119" alt="iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 11/30/2017 - 12:06</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">“If the iFR study is negative, you can trust it,” Allen Jeremias says. But if it’s positive, there’s a chance it’ll be negative at follow-up.</div> Thu, 30 Nov 2017 17:06:36 +0000 yplata 25620 at http://www.tctmd.com TCTMD’s Top 10 Most Popular Stories for November 2017 http://www.tctmd.com/news/tctmds-top-10-most-popular-stories-november-2017 <span class="field field--name-title field--type-string field--label-hidden">TCTMD’s Top 10 Most Popular Stories for November 2017</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/tctmds-top-10-most-popular-stories-november-2017"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/2.7.17.top10.image_.creative.header.jpg?itok=R8hbtAbP" width="220" height="107" alt="TCTMD’s Top 10 Most Popular Stories for November 2017" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 11/29/2017 - 17:10</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/shelley-wood" hreflang="en">Shelley Wood</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The ORBITA study was the hands-down winner for top story this month, but our story on the new hypertension guidelines was also a top contender.</div> Wed, 29 Nov 2017 22:10:20 +0000 yplata 25619 at http://www.tctmd.com Lotus Valve’s Return to Market in Europe Sees Further Delays http://www.tctmd.com/news/lotus-valves-return-market-europe-sees-further-delays <span class="field field--name-title field--type-string field--label-hidden">Lotus Valve’s Return to Market in Europe Sees Further Delays</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/lotus-valves-return-market-europe-sees-further-delays"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/BreakingNews-649x316.jpg?itok=P0F5eB7y" width="220" height="107" alt="Lotus Valve’s Return to Market in Europe Sees Further Delays" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 11/29/2017 - 11:22</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/shelley-wood" hreflang="en">Shelley Wood</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Boston Scientific says problems with the delivery system will set back the valve&#039;s reintroduction to Europe as well as its US market application. </div> Wed, 29 Nov 2017 16:22:30 +0000 yplata 25600 at http://www.tctmd.com Top Stories in Cardiology, November 2017 http://www.tctmd.com/audio/top-stories-cardiology-november-2017 <span class="field field--name-title field--type-string field--label-hidden">Top Stories in Cardiology, November 2017</span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 11/29/2017 - 09:44</span> <div class="field field--name-field-date field--type-datetime field--label-above"> <!-- <div class="field__label">Publish Date</div> --> <div class="field__item">2 weeks ago</div> </div> <div class="field field--name-field-teaser field--type-string-long field--label-above"> <!-- <div class="field__label">Teaser</div> --> <div class="field__item">Heart Sounds with Shelley Wood</div> </div> Wed, 29 Nov 2017 14:44:13 +0000 yplata 25599 at http://www.tctmd.com A Visit With a Cardiologist May Improve A-fib Outcomes http://www.tctmd.com/news/visit-cardiologist-may-improve-fib-outcomes <span class="field field--name-title field--type-string field--label-hidden">A Visit With a Cardiologist May Improve A-fib Outcomes</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/visit-cardiologist-may-improve-fib-outcomes"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/11.28.17.%20A%20Visit%20With%20a%20Cardiologist%20May%20Improve%20A-fib%20Outcomes_1.jpg?itok=bMUgIvtU" width="220" height="127" alt="A Visit With a Cardiologist May Improve A-fib Outcomes" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 11/28/2017 - 17:14</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">More research is needed to know why the care a cardiologist provides may cut the risk of death, one expert says.</div> Tue, 28 Nov 2017 22:14:32 +0000 yplata 25598 at http://www.tctmd.com Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk http://www.tctmd.com/news/nephroprotective-noacs-renal-dysfunction-not-infrequent-among-fib-patients-some-agents-reduce <span class="field field--name-title field--type-string field--label-hidden">Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/nephroprotective-noacs-renal-dysfunction-not-infrequent-among-fib-patients-some-agents-reduce"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/11.28.17%20Nephroprotective%20NOACs%20Renal%20Dysfunction%20Not%20Infrequent%20Among%20A-fib%20Patients%2C%20but%20Some%20Agents%20Reduce%20Risk.jpg?itok=P2mPOaUV" width="220" height="116" alt="Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 11/28/2017 - 16:20</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">There may be some benefit of dabigatran and rivaroxaban over warfarin, but experts question whether lab measurements are enough to warrant a switch. </div> Tue, 28 Nov 2017 21:20:38 +0000 yplata 25597 at http://www.tctmd.com Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA http://www.tctmd.com/news/biotin-supplements-can-interfere-cardiac-troponin-tests-fda <span class="field field--name-title field--type-string field--label-hidden">Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/biotin-supplements-can-interfere-cardiac-troponin-tests-fda"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/11.28.17.Biotin%20Supplements%20Can%20Interfere%20With%20Cardiac%20Troponin%20Tests%20FDA.jpg?itok=RRkAg6ap" width="220" height="126" alt="Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 11/28/2017 - 14:37</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">One person died after excessive levels of biotin, also known as vitamin B7, skewed their troponin test results, according to the FDA.</div> Tue, 28 Nov 2017 19:37:15 +0000 yplata 25596 at http://www.tctmd.com Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate http://www.tctmd.com/news/trajectory-unknown-how-orbita-lands-clinical-practice-still-debate <span class="field field--name-title field--type-string field--label-hidden">Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/trajectory-unknown-how-orbita-lands-clinical-practice-still-debate"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/11.27.17%20Trajectory%20Unknown%20How%20ORBITA%20Lands%20in%20Clinical%20Practice%20Still%20Up%20for%20Debate.jpg?itok=OpWRLCwM" width="220" height="133" alt="Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 11/27/2017 - 15:51</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Reactions to ORBITA ranged from a lone call to downgrade PCI in stable patients to declarations that the provocative trial will have zero impact.</div> Mon, 27 Nov 2017 20:51:01 +0000 yplata 25594 at http://www.tctmd.com Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation http://www.tctmd.com/news/global-improvement-acs-care-seen-regional-clinical-pathway-implementation <span class="field field--name-title field--type-string field--label-hidden">Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/global-improvement-acs-care-seen-regional-clinical-pathway-implementation"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/11.27.17%20Global%20Improvement%20in%20ACS%20Care%20Seen%20With%20Regional%20Clinical%20Pathway%20Implementation.jpg?itok=TjQfTLTG" width="220" height="125" alt="Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 11/27/2017 - 13:57</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Two specific protocols in India and New Zealand have had success in improving optimal care and could be models for other countries.</div> Mon, 27 Nov 2017 18:57:57 +0000 yplata 25593 at http://www.tctmd.com Radial Access Best for PCI Following Thrombolysis in STEMI http://www.tctmd.com/news/radial-access-best-pci-following-thrombolysis-stemi <span class="field field--name-title field--type-string field--label-hidden">Radial Access Best for PCI Following Thrombolysis in STEMI</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/radial-access-best-pci-following-thrombolysis-stemi"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/11.27.17.%20Radial%20Access%20Best%20for%20PCI%20Following%20Thrombolysis%20in%20STEMI.jpg?itok=DwK0wg14" width="220" height="124" alt="Radial Access Best for PCI Following Thrombolysis in STEMI" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 11/27/2017 - 12:35</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Radial access in this high-risk population was associated with not only reduced bleeding and complications, but also lower mortality. </div> Mon, 27 Nov 2017 17:35:26 +0000 yplata 25591 at http://www.tctmd.com New Heart Failure Cases Rising Among Older Adults, MI Survivors http://www.tctmd.com/news/new-heart-failure-cases-rising-among-older-adults-mi-survivors <span class="field field--name-title field--type-string field--label-hidden">New Heart Failure Cases Rising Among Older Adults, MI Survivors </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/new-heart-failure-cases-rising-among-older-adults-mi-survivors"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/New%20Heart%20Failure%20Cases%20Rising%20Among%20Older%20Adults%2C%20MI%20Survivors.11.24.17-header_1.jpg?itok=Cnz5hWbe" width="220" height="118" alt="New Heart Failure Cases Rising Among Older Adults, MI Survivors " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13826" typeof="schema:Person" property="schema:name" datatype="">sgutch</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 11/24/2017 - 14:53</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The UK study found that while total incidence has declined, new HF cases now rival annual rates of the four most common cancers combined.</div> Fri, 24 Nov 2017 19:53:35 +0000 sgutch 25590 at http://www.tctmd.com Methamphetamine Use Growing More Common in Veterans With Heart Failure http://www.tctmd.com/news/methamphetamine-use-growing-more-common-veterans-heart-failure <span class="field field--name-title field--type-string field--label-hidden">Methamphetamine Use Growing More Common in Veterans With Heart Failure</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/methamphetamine-use-growing-more-common-veterans-heart-failure"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/crystal-meth-header_3.jpg?itok=UdOURZd7" width="220" height="147" alt="Methamphetamine Use Growing More Common in Veterans With Heart Failure" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13826" typeof="schema:Person" property="schema:name" datatype="">sgutch</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 11/24/2017 - 14:48</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Users tend to have more psychiatric comorbidities and substance abuse issues, underscoring the need for a multidisciplinary treatment approach.</div> Fri, 24 Nov 2017 19:48:07 +0000 sgutch 25589 at http://www.tctmd.com Pharmacist-Delivered Intervention Boosts Medication Adherence, but Not Risk Factor Control http://www.tctmd.com/news/pharmacist-delivered-intervention-boosts-medication-adherence-not-risk-factor-control <span class="field field--name-title field--type-string field--label-hidden">Pharmacist-Delivered Intervention Boosts Medication Adherence, but Not Risk Factor Control</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/pharmacist-delivered-intervention-boosts-medication-adherence-not-risk-factor-control"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/11.23.2017%20Pharmacist-Delivered%20Intervention%20Boosts%20Medication%20Adherence%2C%20But%20Not%20Risk%20Factor%20Control%20HEADER.jpg?itok=lHua2uff" width="220" height="126" alt="Pharmacist-Delivered Intervention Boosts Medication Adherence, but Not Risk Factor Control" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 11/21/2017 - 16:39</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">It’s possible that a larger improvement in adherence would be needed to have an impact on risk, Tracy Wang says.</div> Tue, 21 Nov 2017 21:39:22 +0000 yplata 25572 at http://www.tctmd.com More Support for TMVR After Failed Mitral Bioprostheses http://www.tctmd.com/news/more-support-tmvr-after-failed-mitral-bioprostheses <span class="field field--name-title field--type-string field--label-hidden">More Support for TMVR After Failed Mitral Bioprostheses</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/more-support-tmvr-after-failed-mitral-bioprostheses"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/MAYRA%20GUERRERO-0099.jpg?itok=Wq1-Pnpb" width="220" height="130" alt="More Support for TMVR After Failed Mitral Bioprostheses" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13826" typeof="schema:Person" property="schema:name" datatype="">sgutch</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 11/22/2017 - 23:09</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Two presentations show good technical and procedural success with the procedure in high-risk patients.</div> Thu, 23 Nov 2017 04:09:56 +0000 sgutch 25573 at http://www.tctmd.com ‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry http://www.tctmd.com/news/acceptable-safety-laa-closure-seen-real-world-all-comers-registry <span class="field field--name-title field--type-string field--label-hidden">‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/acceptable-safety-laa-closure-seen-real-world-all-comers-registry"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/watchman-header%20updated.jpg?itok=YPxodQrL" width="220" height="119" alt="‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 11/21/2017 - 14:31</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The data show that LAA closure with various devices can be done with a low major complication risk, one expert says.</div> Tue, 21 Nov 2017 19:31:16 +0000 yplata 25570 at http://www.tctmd.com My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self http://www.tctmd.com/news/my-takeaways-tct-2017-show-keep-it-civil-and-bring-your-best-self <span class="field field--name-title field--type-string field--label-hidden">My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/my-takeaways-tct-2017-show-keep-it-civil-and-bring-your-best-self"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/11.21.17%20My%20Takeaways%20From%20TCT%202017%20Show%20Up%2C%20Keep%20It%20Civil%2C%20and%20Bring%20Your%20Best%20Self%20HEADER.jpg?itok=_qXNAKKQ" width="220" height="127" alt="My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 11/21/2017 - 15:58</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/shelley-wood" hreflang="en">Shelley Wood</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">ORBITA grabbed the headlines at TCT this year. How it was received both on-site and in the weeks that followed holds lessons for us all. </div> Tue, 21 Nov 2017 20:58:47 +0000 yplata 25571 at http://www.tctmd.com Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis http://www.tctmd.com/news/routine-coronary-cta-rule-out-acs-acute-chest-pain-questioned-romicat-ii-subanalysis <span class="field field--name-title field--type-string field--label-hidden">Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/routine-coronary-cta-rule-out-acs-acute-chest-pain-questioned-romicat-ii-subanalysis"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/11.21.2017.%20Routine%20Coronary%20CTA%20to%20Rule%20Out%20ACS%20in%20Acute%20Chest%20Pain%20Questioned%20in%20ROMICAT-II%20Subanalysis.jpg?itok=OVl1PSHG" width="220" height="119" alt="Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 11/21/2017 - 12:28</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The subanalysis of 118 patients contradicts the main results of the trial, which endorsed the merits of noninvasive testing in the ED.</div> Tue, 21 Nov 2017 17:28:50 +0000 yplata 25569 at http://www.tctmd.com Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I http://www.tctmd.com/news/novel-interatrial-shunt-succeeds-hf-hemodynamic-study-reduce-lap-hf-i <span class="field field--name-title field--type-string field--label-hidden">Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/novel-interatrial-shunt-succeeds-hf-hemodynamic-study-reduce-lap-hf-i"><img src="/sites/default/files/efs/public/styles/medium/public/2017-11/corvia1_image.jpg?itok=gjeXF9AL" width="220" height="120" alt="Novel Interatrial Shunt Succeeds in HF Hemodynamic Study " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 11/21/2017 - 10:14</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The study sets the stage for larger trials and offers hope for patients with HFpEF, who have limited treatment options, say researchers.</div> Tue, 21 Nov 2017 15:14:47 +0000 yplata 25567 at http://www.tctmd.com